ASHP Midyear Clinical Meeting & Exhibition

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed potential safety concerns and the pharmacist’s role in managing insulin.

During her time at ASHP Midyear 2025, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, returned to discuss all available insulin pump options.

Prateek Bhatia, PhD, discusses barriers to accessing infusion center services and how the pharmacist can alleviate patient challenges.

McKesson’s Ginger Thorpe discusses the gaps and opportunities in specialty pharmacy’s approach toward care coordination within health systems.

The ASHP Midyear Meeting 2025 showcases pharmacy's evolution, emphasizing teamwork, specialized roles, and innovative strategies to enhance patient care and outcomes.

Pharmacists navigate the evolving landscape of cannabis, balancing patient expectations with emerging evidence on cannabidiol and tetrahydrocannabinol for various medical conditions.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss the immense role automation has shouldered within pharmacy compounding.

Progress against the opioid crisis shows promise, with overdose deaths declining, and pharmacists play a crucial role in life-saving medication strategies.

Explore the complexities of cannabinoids, focusing on cannabidiol and tetrahydrocannabinol, their effects, side effects, and potential drug interactions in modern use.

Pediatric obesity rates surge, prompting a debate on GLP-1 agonists versus traditional treatments, highlighting efficacy, risks, and long-term implications.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss various roles in centralized IV compounding and robotics.

Annie Lambert, PharmD, BCSCP, discusses compliance solutions and the common gaps existing in the pharmacy compounding industry today.

Pharmacists play a vital role in integrating diabetes and depression care, enhancing patient outcomes through screening, individualized treatment, and collaborative approaches.

Lani Bertrand, RPh, discusses Omnicell’s IV compounding solution and how it’s realizing cost savings for pharmacies across the country.

Caitlin Clark shares insights on teamwork and confidence in health care and sports, emphasizing the importance of relationships for success.

Pharmacy technicians evolve into specialized clinical roles, enhancing patient care and reducing turnover.

The evolving landscape of type 2 diabetes management with advanced insulin delivery systems enhances patient outcomes and pharmacist roles.

Misinformation, limited understanding of biosimilars, and inconsistent insurance policies only add to the confusion.

As hospitals and health systems aim to improve outcomes, pharmacists have a large role in managing these conditions with pregnancy-specific therapies.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

A conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia, on RSV vaccine recommendations.

Drug Topics met with Lourdes Cross, PharmD, BCACP, CDCES, to discuss pharmacists’ role in managing patients’ chronic obstructive pulmonary disease.

Two posters presented at the meeting looked into the topic CGMs in diabetes care.

Experts conducted a study to better understand how ambulatory care pharmacist services impacted patient outcomes, provider workload, and access to care.

Drug Topics met with Amanuel Kehasse, PharmD, PhD, to discuss the barriers surrounding biosimilar implementation in the prescription drug market.

Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.

Kathryn Litten, PharmD, discussed the pharmacist’s role in helping patients manage metabolic dysfunction-associated steatotic liver disease.

A conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.

Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients’ exacerbations.